Evaluating the Efficacy and Feasibility of a Novel Wireless ECG Recording System in Monitoring Patients After Atrial Fibrillation Ablation Procedure
NCT ID: NCT01912911
Last Updated: 2014-08-07
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
60 participants
OBSERVATIONAL
2013-06-30
2014-06-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
A secondary goal is to assess the ease of use of AliveCor device compared to traditional TTM system from the patient's perspective
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Using Smart Phone Technology in Detecting the Presence of Atrial Fibrillation
NCT02214069
Respiratory Motion Related Ablation Gap and Clinical Outcome After Catheter Ablation for Atrial Fibrillation
NCT02216903
Wearable Cardiac Monitor to Enhance Detection of Arrhythmia Recurrence After Catheter Ablation of Atrial Fibrillation
NCT06564012
ICT-based Monitoring for Arrhythmia Detection After AF Ablation
NCT03256812
Implanted Loop Recorder Post Atrial Fibrillation Ablation
NCT00915720
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
CASE_ONLY
PROSPECTIVE
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
2. Paroxysmal or persistent atrial fibrillation
3. Scheduled to undergo an AF ablation procedure
4. Already has iPhone 4 or iPhone 4S with data plan
5. Willing to use the iPhone Alive Cor case
6. Written informed consent
Exclusion Criteria
2. Residing outside the United States
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
The Cleveland Clinic
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Khaldoun Tarakji
MD MPH
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Khaldoun Tarajki, MD
Role: PRINCIPAL_INVESTIGATOR
The Cleveland Clinic
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Cleveland Clinic HVI
Cleveland, Ohio, United States
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
13-521
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.